发明名称 |
QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION |
摘要 |
<p>The present invention provides a quinolone compound that inhibits the chronic progression of Parkinson's disease or protects dopamine neurons from disease etiology, thereby suppressing the progression of neurological dysfunction, so as to prolong the period of time until L-dopa is administered while also improving neuronal function; the quinolone compound of the invention is represented by Formula (1): wherein: R1 represents hydrogen or the like; R2 represents hydrogen or the like; R3 represents substituted or unsubstituted phenyl or the like; R4 represents halogen or the like; R5 represents hydrogen or the like; R6 represents hydrogen or the like; and R7 represents hydrogen or the like.</p> |
申请公布号 |
KR20100091149(A) |
申请公布日期 |
2010.08.18 |
申请号 |
KR20107002390 |
申请日期 |
2009.12.04 |
申请人 |
OTSUKA PHARMACEUTICAL CO., LTD. |
发明人 |
OTSUBO KENJI;YAMAUCHI TAKAHITO;OCHI YUJI |
分类号 |
C07D215/233;A61K31/47;A61P25/16;C07D401/06 |
主分类号 |
C07D215/233 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|